Skip to main content
Log in

Cognitive impairment in testicular cancer survivors 2 to 7 years after treatment

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

The aim of the present study was to determine the prevalence of cognitive impairment (CI) in a group of testicular (TC) survivors by comparing their neuropsychological test scores with normative data and to assess their performance in specific cognitive domains.

Methods

Seventy-two TC survivors were evaluated 2 to 7 years post-treatment with a neuropsychological test battery that assessed multiple cognitive domains—attention and working memory, processing speed, verbal fluency, learning and memory, and executive functioning. Test scores were compared with normative data, and CI status was calculated for each participant.

Results

In group-level analyses, survivors exhibited significantly impaired scores on a majority (9/12) of the neuropsychological outcomes (p < 0.01). In individual-level analyses, 62.5 % of the survivors were classified as having CI, significantly exceeding the expected normative frequency of 25 % (binomial test: p < 0.001). In particular, CI was observed in multiple outcomes related to verbal learning and memory (29 to 33 % of participants), visual learning and memory (14–28 %), processing speed (8–24 %), executive functioning (17 %), and attention and working memory (4–15 %). No association was found between treatment modality (surgery ± chemotherapy) and CI.

Conclusions

The prevalence of CI in TC survivors was unexpectedly high, with survivors performing significantly worse than expected on a majority of the neuropsychological outcomes. While the findings are preliminary in nature, they still have important implications for the diagnosis and treatment of CI in TC survivors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Zachariae R, Mehlsen MY (2011) Is chemotherapy associated with cognitive impairment? Nat Rev Urol 8:182–3. doi:10.1038/nrurol.2011.29

    Article  CAS  PubMed  Google Scholar 

  2. Schagen SB, Boogerd W, Muller MJ et al (2008) Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer. Acta Oncol 47:63–70. doi:10.1080/02841860701518058

    Article  CAS  PubMed  Google Scholar 

  3. Pedersen AD, Rossen P, Mehlsen MY et al (2009) Long-term cognitive function following chemotherapy in patients with testicular cancer. J Int Neuropsychol Soc 15:296–301. doi:10.1017/S1355617709090316

    Article  CAS  PubMed  Google Scholar 

  4. Skaali T, Fosså SD, Andersson S et al (2011) A prospective study of neuropsychological functioning in testicular cancer patients. Ann Oncol 22:1062–70. doi:10.1093/annonc/mdq553

    Article  CAS  PubMed  Google Scholar 

  5. Wefel JS, Vidrine DJ, Veramonti TL et al (2011) Cognitive impairment in men with testicular cancer prior to adjuvant therapy. Cancer 117:190–6. doi:10.1002/cncr.25298

    Article  PubMed  Google Scholar 

  6. Wefel JS, Vidrine DJ, Marani SK et al (2014) A prospective study of cognitive function in men with non-seminomatous germ cell tumors. Psychooncology 23:626–33. doi:10.1002/pon.3453

    Article  PubMed Central  PubMed  Google Scholar 

  7. Groll RJ, Warde P, Jewett MAS (2007) A comprehensive systematic review of testicular germ cell tumor surveillance. Crit Rev Oncol Hematol 64:182–97. doi:10.1016/j.critrevonc.2007.04.014

    Article  CAS  PubMed  Google Scholar 

  8. Travis LB, Beard C, Allan JM et al (2010) Testicular cancer survivorship: research strategies and recommendations. J Natl Cancer Inst 102:1114–30. doi:10.1093/jnci/djq216

    Article  PubMed Central  PubMed  Google Scholar 

  9. Boykoff N, Moieni M, Subramanian SK (2009) Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response. J Cancer Surviv 3:223–232. doi:10.1007/s11764-009-0098-x

    Article  PubMed Central  PubMed  Google Scholar 

  10. Calvio L, Peugeot M, Bruns GL et al (2010) Measures of cognitive function and work in occupationally active breast cancer survivors. J Occup Environ Med 52:219–27. doi:10.1097/JOM.0b013e3181d0bef7

    Article  PubMed  Google Scholar 

  11. Wu LM, Austin J, Hamilton JG et al (2012) Self-efficacy beliefs mediate the relationship between subjective cognitive functioning and physical and mental well-being after hematopoietic stem cell transplant. Psychooncology 21:1175–84. doi:10.1002/pon.2012

    Article  PubMed Central  PubMed  Google Scholar 

  12. Wefel JS, Vardy J, Ahles T, Schagen SB (2011) International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol 12:703–8. doi:10.1016/S1470-2045(10)70294-1

    Article  PubMed  Google Scholar 

  13. Ingraham LJ, Aiken CB (1996) An empirical approach to determining criteria for abnormality in test batteries with multiple measures. Neuropsychology 10:120–124

    Article  Google Scholar 

  14. Nielsen H, Knudsen L, Daugbjerg O (1989) Normative data for eight neuropsychological tests based on a Danish sample. Scand J Psychol 30:37–45

    Article  CAS  PubMed  Google Scholar 

  15. Jørgensen K (2012) Danske normer til neuropsykologiske tests. Dansk Psykologisk Forlag

  16. Wechsler D (2009) WAIS-III Wechsler Adult Intelligence Scale-III: Vejledning (På dansk ved Thomsen H & Jørgensen K). Dansk Psykolog Forlag, København

    Google Scholar 

  17. Reitan RM (1958) Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 8:271–276

    Article  Google Scholar 

  18. Thurstone LL, Thurstone TG (1962) Primary mental abilities. Science Research Associates, Chicago

    Google Scholar 

  19. Schmidt M (1996) Auditory and verbal learning test. A handbook. Western Psychological Services, Los Angeles

    Google Scholar 

  20. Meyers J, Meyers K (1995) Rey Complex Figure and Recognition Trial: professional manual. Psychological Assessment Resources, Odessa

    Google Scholar 

  21. Hjorthøj CR, Vesterager L, Nordentoft M (2013) Test-retest reliability of the Danish Adult Reading Test in patients with comorbid psychosis and cannabis-use disorder. Nord J Psychiatry 67:159–63. doi:10.3109/08039488.2012.691544

    Article  PubMed  Google Scholar 

  22. Ryan JJ, Paolo AM (1992) A screening procedure for estimating premorbid intelligence in the elderly. Clin Neuropsychol 6:53–62

    Article  Google Scholar 

  23. Cohen S, Kamarck T, Mermelstein R (1983) A global measure of perceived stress. J Health Soc Behav 24:385–96

    Article  CAS  PubMed  Google Scholar 

  24. Beck AT, Steer RA, Brown GK (1996) Manual for the Beck Depression Inventory 2. Psychological Corporation, San Antonio

    Google Scholar 

  25. Danmarks Statistik. http://www.dst.dk/da/Statistik/emner/fuldtidsuddannelser/alle-uddannelser.aspx

  26. Cohen S, Janicki-Deverts D (2012) Who’s stressed? Distributions of psychological stress in the United States in probability samples from 1983, 2006, and 20091. J Appl Soc Psychol 42:1320–1334. doi:10.1111/j.1559-1816.2012.00900.x

    Article  Google Scholar 

  27. Ahles TA, Saykin AJ, McDonald BC et al (2010) Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol 28:4434–40. doi:10.1200/JCO.2009.27.0827

    Article  PubMed Central  PubMed  Google Scholar 

  28. Scherwath A, Schirmer L, Kruse M et al (2013) Cognitive functioning in allogeneic hematopoietic stem cell transplantation recipients and its medical correlates: a prospective multicenter study. Psychooncology 22:1509–16. doi:10.1002/pon.3159

    Article  PubMed  Google Scholar 

  29. Bandak M, Aksglaede L, Juul A et al (2011) The pituitary-Leydig cell axis before and after orchiectomy in patients with stage I testicular cancer. EurJCancer 47:2585–2591

    CAS  Google Scholar 

  30. Nord C, Bjøro T, Ellingsen D et al (2003) Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer. Eur Urol 44:322–8

    Article  PubMed  Google Scholar 

  31. Beauchet O (2006) Testosterone and cognitive function: current clinical evidence of a relationship. Eur J Endocrinol 155:773–81. doi:10.1530/eje.1.02306

    Article  CAS  PubMed  Google Scholar 

  32. Lippitz BE (2013) Cytokine patterns in patients with cancer: a systematic review. Lancet Oncol 14:e218–28. doi:10.1016/S1470-2045(12)70582-X

    Article  CAS  PubMed  Google Scholar 

  33. Reichenberg A, Yirmiya R, Schuld A et al (2001) Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58:445–52

    Article  CAS  PubMed  Google Scholar 

  34. Wilson CJ, Finch CE, Cohen HJ (2002) Cytokines and cognition-the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc 50:2041–2056. doi:10.1046/j.1532-5415.2002.50619.x

    Article  PubMed  Google Scholar 

  35. Vardy J, Rourke S, Galica J et al (2006) Cytokine levels in patients (pts) with localized colorectal cancer (CRC) after surgery and their relationship to fatigue and cognitive function. ASCO Meet Abstr 24:3623

    Google Scholar 

  36. Ahles TA, Saykin AJ (2007) Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 7:192–201. doi:10.1038/nrc2073

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  37. Lezak MD, Howieson DB, Bigler ED, Tranel D (2012) Neuropsychological assessment, 5th edn. Oxford University Press, New York

    Google Scholar 

  38. Vogel A, Stokholm J, Jørgensen K (2012) Performances on Rey Auditory Verbal Learning Test and Rey Complex Figure Test in a healthy, elderly Danish sample—reference data and validity issues. Scand J Psychol 53:26–31. doi:10.1111/j.1467-9450.2011.00909.x

    Article  PubMed  Google Scholar 

  39. Hutchinson AD, Hosking JR, Kichenadasse G et al (2012) Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review. Cancer Treat Rev 38:926–34. doi:10.1016/j.ctrv.2012.05.002

    Article  PubMed  Google Scholar 

  40. Pullens MJJ, De Vries J, Roukema JA (2010) Subjective cognitive dysfunction in breast cancer patients: a systematic review. Psychooncology 19:1127–38. doi:10.1002/pon.1673

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The study was supported by grants from the Danish Cancer Society and by Saværksejer Jeppe Juhls og Hustru Ovita Juhls Mindelegat. We thank all the TC survivors who participated in this study for their time and dedication.

Conflict of interest

The authors declare that there is no conflict of interest. They also state that they have full control of primary data and that they agree to allow the journal to review their data if requested.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ali Amidi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Amidi, A., Wu, L.M., Pedersen, A.D. et al. Cognitive impairment in testicular cancer survivors 2 to 7 years after treatment. Support Care Cancer 23, 2973–2979 (2015). https://doi.org/10.1007/s00520-015-2663-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-015-2663-3

Keywords

Navigation